Literature DB >> 22074748

Summary of findings from the OPPERA baseline case-control study: implications and future directions.

Roger B Fillingim1, Gary D Slade, Luda Diatchenko, Ronald Dubner, Joel D Greenspan, Charles Knott, Richard Ohrbach, William Maixner.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22074748      PMCID: PMC3232405          DOI: 10.1016/j.jpain.2011.08.009

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


× No keyword cloud information.
  11 in total

1.  Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  William Maixner; Joel D Greenspan; Ronald Dubner; Eric Bair; Flora Mulkey; Vanessa Miller; Charles Knott; Gary D Slade; Richard Ohrbach; Luda Diatchenko; Roger B Fillingim
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  Roger B Fillingim; Richard Ohrbach; Joel D Greenspan; Charles Knott; Ronald Dubner; Eric Bair; Cristina Baraian; Gary D Slade; William Maixner
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

3.  Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study.

Authors:  Gary D Slade; Eric Bair; Kunthel By; Flora Mulkey; Cristina Baraian; Rebecca Rothwell; Maria Reynolds; Vanessa Miller; Yoly Gonzalez; Sharon Gordon; Margarete Ribeiro-Dasilva; Pei Feng Lim; Joel D Greenspan; Ron Dubner; Roger B Fillingim; Luda Diatchenko; William Maixner; Dawn Dampier; Charles Knott; Richard Ohrbach
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

4.  Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study.

Authors:  Joel D Greenspan; Gary D Slade; Eric Bair; Ronald Dubner; Roger B Fillingim; Richard Ohrbach; Charlie Knott; Flora Mulkey; Rebecca Rothwell; William Maixner
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

5.  Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study.

Authors:  Shad B Smith; Dylan W Maixner; Joel D Greenspan; Ronald Dubner; Roger B Fillingim; Richard Ohrbach; Charles Knott; Gary D Slade; Eric Bair; Dustin G Gibson; Dmitri V Zaykin; Bruce S Weir; William Maixner; Luda Diatchenko
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

6.  Orofacial pain prospective evaluation and risk assessment study--the OPPERA study.

Authors:  William Maixner; Luda Diatchenko; Ronald Dubner; Roger B Fillingim; Joel D Greenspan; Charles Knott; Richard Ohrbach; Bruce Weir; Gary D Slade
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

Review 7.  The role of psychosocial factors in temporomandibular disorders.

Authors:  G B Rollman; J M Gillespie
Journal:  Curr Rev Pain       Date:  2000

Review 8.  Epidemiology of temporomandibular disorders: implications for the investigation of etiologic factors.

Authors:  L LeResche
Journal:  Crit Rev Oral Biol Med       Date:  1997

Review 9.  Psychological considerations for chronic orofacial pain.

Authors:  Charles R Carlson
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2008-05       Impact factor: 2.802

Review 10.  Psychosocial factors in the etiology, diagnosis and management of temporomandibular disorders.

Authors:  Ilana Eli
Journal:  Alpha Omegan       Date:  2003-07
View more
  21 in total

1.  Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study.

Authors:  Joel D Greenspan; Gary D Slade; Eric Bair; Ronald Dubner; Roger B Fillingim; Richard Ohrbach; Charlie Knott; Flora Mulkey; Rebecca Rothwell; William Maixner
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  Richard Ohrbach; Roger B Fillingim; Flora Mulkey; Yoly Gonzalez; Sharon Gordon; Henry Gremillion; Pei-Feng Lim; Margarete Ribeiro-Dasilva; Joel D Greenspan; Charles Knott; William Maixner; Gary Slade
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

Review 3.  The Role of Psychosocial Processes in the Development and Maintenance of Chronic Pain.

Authors:  Robert R Edwards; Robert H Dworkin; Mark D Sullivan; Dennis C Turk; Ajay D Wasan
Journal:  J Pain       Date:  2016-09       Impact factor: 5.820

4.  A pain research agenda for the 21st century.

Authors:  Robert W Gereau; Kathleen A Sluka; William Maixner; Seddon R Savage; Theodore J Price; Beth B Murinson; Mark D Sullivan; Roger B Fillingim
Journal:  J Pain       Date:  2014-10-29       Impact factor: 5.820

5.  Summary of findings from the OPPERA prospective cohort study of incidence of first-onset temporomandibular disorder: implications and future directions.

Authors:  Gary D Slade; Roger B Fillingim; Anne E Sanders; Eric Bair; Joel D Greenspan; Richard Ohrbach; Ronald Dubner; Luda Diatchenko; Shad B Smith; Charles Knott; William Maixner
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

6.  Genetic variants associated with development of TMD and its intermediate phenotypes: the genetic architecture of TMD in the OPPERA prospective cohort study.

Authors:  Shad B Smith; Ellen Mir; Eric Bair; Gary D Slade; Ronald Dubner; Roger B Fillingim; Joel D Greenspan; Richard Ohrbach; Charles Knott; Bruce Weir; William Maixner; Luda Diatchenko
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

7.  Premorbid and concurrent predictors of TMD onset and persistence.

Authors:  Richard Ohrbach; Gary D Slade; Eric Bair; Nuvan Rathnayaka; Luda Diatchenko; Joel D Greenspan; William Maixner; Roger B Fillingim
Journal:  Eur J Pain       Date:  2019-08-29       Impact factor: 3.931

Review 8.  Perspectives on next steps in classification of oro-facial pain - part 2: role of psychosocial factors.

Authors:  J Durham; K G Raphael; R Benoliel; W Ceusters; A Michelotti; R Ohrbach
Journal:  J Oral Rehabil       Date:  2015-08-08       Impact factor: 3.837

Review 9.  Modulation of Pathological Pain by Epidermal Growth Factor Receptor.

Authors:  Jazlyn P Borges; Katrina Mekhail; Gregory D Fairn; Costin N Antonescu; Benjamin E Steinberg
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

Review 10.  Perspectives on next steps in classification of oro-facial pain - part 1: role of ontology.

Authors:  W Ceusters; A Michelotti; K G Raphael; J Durham; R Ohrbach
Journal:  J Oral Rehabil       Date:  2015-07-25       Impact factor: 3.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.